Variant report
Variant | nsv551034 |
---|---|
Chromosome Location | chr10:57035385-57068476 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:5)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:5 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr10:57063877..57064377-chr19:2475827..2476338,2 | HCT-116 | colon: | |
2 | chr10:57047149..57047763-chr10:57389634..57390254,2 | MCF-7 | breast: | |
3 | chr10:57046815..57047629-chr10:57390561..57391169,3 | MCF-7 | breast: | |
4 | chr10:57046804..57047423-chr10:57260630..57261301,2 | MCF-7 | breast: | |
5 | chr10:57045296..57046208-chr13:38876652..38877471,2 | MCF-7 | breast: |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000099860 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs563192712 | chr10:57041605-57041606 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs578255056 | chr10:57041631-57041632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs79252960 | chr10:57041642-57041643 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs530617294 | chr10:57041657-57041658 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs116231095 | chr10:57041665-57041666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs563953758 | chr10:57041668-57041669 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs529333955 | chr10:57041669-57041670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs59504903 | chr10:57041688-57041689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs192322419 | chr10:57041691-57041692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs60520924 | chr10:57041699-57041700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs549355933 | chr10:57041735-57041736 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs559629496 | chr10:57041776-57041777 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs183642125 | chr10:57041779-57041780 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs551310461 | chr10:57041806-57041807 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs200740857 | chr10:57041835-57041836 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs185387786 | chr10:57041884-57041885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs550489691 | chr10:57042029-57042030 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs561194235 | chr10:57042114-57042115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs535912173 | chr10:57042124-57042125 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs552893969 | chr10:57042136-57042137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs572852115 | chr10:57042139-57042140 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs538697965 | chr10:57042164-57042165 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs558396751 | chr10:57042225-57042226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs530216891 | chr10:57042231-57042232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs578232864 | chr10:57042239-57042240 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs544008706 | chr10:57042269-57042270 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs564017375 | chr10:57042308-57042309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs144592971 | chr10:57042410-57042411 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs34913468 | chr10:57042463-57042464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs371210195 | chr10:57042469-57042470 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs542664877 | chr10:57042475-57042476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs7083769 | chr10:57042478-57042479 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs528595024 | chr10:57042495-57042496 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs189994727 | chr10:57042563-57042564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs182200065 | chr10:57042571-57042572 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs561049492 | chr10:57042610-57042611 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs7071104 | chr10:57042637-57042638 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs550354260 | chr10:57042674-57042675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs140287371 | chr10:57042715-57042716 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs536501930 | chr10:57042754-57042755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs546299122 | chr10:57042800-57042801 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs145299170 | chr10:57042846-57042847 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs148352943 | chr10:57042848-57042849 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs377350068 | chr10:57042862-57042863 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs568969469 | chr10:57042867-57042868 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs112854668 | chr10:57042876-57042877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs187343538 | chr10:57042877-57042878 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs574253967 | chr10:57042932-57042933 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs543272602 | chr10:57042935-57042936 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs12256802 | chr10:57042977-57042978 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Autism | 20858243 | CNVD |
Breast cancer | 22522925 | CNVD |
Usher type I cohort | 17277737 | CNVD |
Usher type I cohort | 21436283 | CNVD |
Leukemia | 21357790 | CNVD |
Medulloblastoma | 22832581 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:57041600-57044200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr10:57042800-57043400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
3 | chr10:57044200-57045600 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
4 | chr10:57045600-57046000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
5 | chr10:57055800-57056400 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
6 | chr10:57065000-57065600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
7 | chr10:57068000-57068600 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |